tiprankstipranks
Trending News
More News >
Waverley Pharma (TSE:WAVE)
:WAVE
Canadian Market

Waverley Pharma (WAVE) Income Statement

Compare
5 Followers

Waverley Pharma Income Statement

Last quarter (Q0 0), Waverley Pharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Waverley Pharma's net income was $-272.91K. See Waverley Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 79.80K$ 581.78K$ 222.67K$ 181.71K$ 48.94K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 942.62K$ ―$ ―$ ―$ ―
EBITDA
$ -1.72M$ -435.33K$ -726.25K$ ―$ ―
Operating Income
$ -2.23M$ -638.16K$ -786.83K$ -709.60K$ -1.41M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -2.22M$ -664.08K$ -796.51K$ -705.76K$ -1.21M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Waverley Pharma Earnings and Revenue History